140 - APPROPRIATE THERAPY FOLLOWING INSERTION OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR FOR PRIMARY AND SECONDARY PREVENTION
A Qi, P Uerojanaunjoltul, CR Kerr, KH Humphries, J Boone, S Tung, S Flavelle, C McIlroy, JA Yeung-Lai-Wah
Vancouver, British Columbia

141 - MICROVOLT REPOLARIZATION ALTERNANS IDENTIFIES RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY
DV Exner, K Cowan, DG Wyse, LB Mitchell, RS Sheldon, AM Gillis, KM Kavanagh, HJ Duff
Calgary, Alberta

142 - WHEN DOES LIMITED ICD MAKE ECONOMIC SENSE?
DR Davis, D Coyle, DH Birnie, G Wells, R Lemery, MS Green, M Gollob, AS Tang
Ottawa, Ontario

143 - COMPARISON OF LEAD DISLODGEMENT RATES IN ACTIVE VERSUS PASSIVE FIXATION ENDOCARDIAL PACING AND DEFIBRILLATION LEADS IMPLANTED IN THE RIGHT VENTRICLE
PG Novak, M Dubuc, I Greiss, P Dieuzaide, A Furlani, PG Guerra, L Macle, D Roy, R Cartier, M Talajic, B Thibault
Montreal, Quebec

144 - CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH SYMPTOMATIC HEART FAILURE: A SYSTEMATIC REVIEW
JA Ezekowitz, FA McAlister, N Wiebe, B Rowe, C Spooner, E Crumley, L Hartling, T Klassen, WT Abraham
Edmonton, Alberta; Columbus, Ohio, USA

145 - AN UNEXPECTEDLY HIGH RATE OF REPLACEMENT OF A NEWER GENERATION POLYURETHANE PACEMAKER LEAD: A LONG TERM FOLLOW-UP STUDY
JL Sapp, M Shields, J Douglas, MN Basta, WJ Sheridan, MJ Gardner
Halifax, Nova Scotia

146 - LOW INCIDENCE OF VENOUS THROMBOSIS AFTER ICD OR BIVENTRICULAR IMPLANTS IN THE MODERN ERA
J Champagne, F Philippon, G OHara, F Molin, L Blier, L Dufort, M Gilbert
Quebec, Quebec

147 - GENDER DISPARITY IN IMPLANTED CARDIOVERTER DEFIBRILLATOR THERAPY
DR Davis, EW Lau, AS Tang, MG Green, R Lemery, MJ Gollob, DH Birnie
Ottawa, Ontario

148 - CONTINUOUS LEAD IMPEDANCE MONITORING TO ASSESS ADEQUACY OF PACEMAKER LEAD FIXATION
R Yee, DL Jones, R Papp, GM Guiraudon, GJ Klein, AD Krahn, AC Skanes, M German, D Carlson
London, Ontario